Efficacy and Safety of Mirikizumab in Psoriasis Efficacy and Safety of Mirikizumab in Psoriasis

This Phase III study evaluated the efficacy and safety of the interleukin-23 inhibitor mirikizumab in adult patients with moderate-to-severe plaque psoriasis.The British Journal of Dermatology
Source: Medscape Today Headlines - Category: Consumer Health News Tags: Dermatology Journal Article Source Type: news